BMS Allows Additional Contract Pharmacy Designation for Cancer Drug; Vertex Adds Cystic Fibrosis Drug to Restrictions
Drugmakers Bristol Myers Squibb (BMS) and Vertex have each announced changes to their 340B contract pharmacy restrictions that apply to [...]